![]() | Up a level |
Journal Article
Ben Khaled, Najib, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Roessler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael ORCID: 0000-0002-4463-8263, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom
ORCID: 0000-0002-6288-8821, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N.
(2022).
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Future Oncol., 18 (12).
S. 1423 - 1436.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1744-8301
De Toni, Enrico N., Kubisch, Ilja, Ben Khaled, Najib, Ricke, Jens, Mayerle, Julia, Ehmer, Ursula, Waldschmidt, Dirk, Roessler, Daniel Christoph, Oehrle, Bettina, Bitzer, Michael, Kandulski, Arne, Reuken, Philipp A., Wege, Henning and Seidensticker, Max (2022). Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: The DEMAND randomized phase II clinical trial. J. Clin. Oncol., 40 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Mohnike, Konrad, Steffen, Ingo G., Seidensticker, Max, Hass, Peter ORCID: 0000-0003-0164-5284, Damm, Robert, Peters, Nils, Seidensticker, Ricarda, Schuette, Kerstin, Arend, Joerg, Bornschein, Jan
ORCID: 0000-0001-8673-3122, Streitparth, Tina, Wybranski, Christian, Wieners, Gero, Stuebs, Patrick, Malfertheiner, Peter, Pech, Maciej and Ricke, Jens
(2019).
Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial.
Cardiovasc. Interv. Radiol., 42 (2).
S. 239 - 250.
NEW YORK:
SPRINGER.
ISSN 1432-086X
Nass, Norbert ORCID: 0000-0003-2563-0386, Streit, Sebastian, Wybranski, Christian, Juergens, Julian, Brauner, Jan, Schulz, Nadine, Powerski, Maciej, Ricke, Jens, Kalinski, Thomas, Dudeck, Oliver and Seidensticker, Max
ORCID: 0000-0002-2481-5410
(2017).
Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Anticancer Res., 37 (1).
S. 87 - 94.
ATHENS:
INT INST ANTICANCER RESEARCH.
ISSN 1791-7530